Get started
Work

Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics

Year: 2019
Type: article
DOI: 10.1007/s11606-019-05432-6
Authors: Aishwarya Vijay, Ravi Gupta, Patrick Liu, Sanket S. Dhruva, Nilay D. Shah, Joseph S. Ross
Institutions: Yale University, Johns Hopkins University, Johns Hopkins Medicine, Johns Hopkins Hospital, San Francisco VA Medical Center, University of California, San Francisco, Mayo Clinic, Yale New Haven Health System
Language: English
Open Access status: bronze
Funders: National Science Foundation, Yale University, Patient-Centered Outcomes Research Institute, Laura and John Arnold Foundation, National Institutes of Health, U.S. Food and Drug Administration, Agency for Healthcare Research and Quality, Center of Excellence in Regulatory Science and Innovation, National Heart, Lung, and Blood Institute, National Center for Advancing Translational Sciences
Awards: G1009113317, G122417246, G1255676775, G1384350020, Diffusion of Clinical Evidence into Practice: Physician Networks, Delivery Organizations, and Markets, G1759066555, G225606699, Shared decision making for stroke prevention in atrial fibrillation (SDM4Afib), G4117802685, G4208500296, G4883553062, G5256588396, G5261932612, G600064212, G7168163869, G7263091383, G747006993, G7983798716, UNDERSTANDING HOSPITAL READMISSION RATES: PATIENT, HOSPITAL AND COMMUNITY EFFECTS, G8313649646, G8475715394, Yale Clinical and Translational Science Award
OpenAlex ID: W2980897012
FWCI: 1.247
Cites: 5
Cited by: 4
Related to: 10